Certolizumab Pegol [certolizumab pegol]
topical
47
- Terms
-
certolizumab pegovaný
Cimzia
kertolizumab pegol
-
CDP 870
CDP870
Cimzia
Persistent link
https://www.medvik.cz/link/D000068582
Definition
A polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
- DUI
- D000068582 MeSH Browser
- CUI
- M0507051
- History note
- 2016 (2003)
- Public note
- 2016; CERTILIZUMAB PEGOL was indexed under IMMUNOGLOBULIN FAB FRAGMENTS 2003-2015, POLYETHYLENE GLYCOLS 2003-2015, and under ANTIBODIES, MONOCLONAL, HUMANIZED 2003-2015
Allowable subheadings
- AD
- administration & dosage 12
- AE
- adverse effects 5
- AN
- analysis 0
- BI
- biosynthesis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CH
- chemistry 0
- CL
- classification 0
- DE
- drug effects 0
- EC
- economics 1
- GE
- genetics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 1
- PK
- pharmacokinetics 1
- PD
- pharmacology 10
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- TU
- therapeutic use 20
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0
...
Occurrences in Medvik records